Form 4 for RMD ResMed|
Accepted 2024-12-05 00:00:00 ET · period of report 2024-12-04 · accession 0001127602-24-028741 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-05 | 2024-12-04 | RMD | FARRELL PETER C | Dir | S - Sale | $245.65 | -2,000 | 81.2K | -2% | -$491.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2024-12-04 | S | D | 2,000 | $245.65 | 81,218 | D | — | — |